A carregar...
Targeting Interleukins for the Treatment of Inflammatory Bowel Disease—What Lies Beyond Anti-TNF Therapy?
Inflammatory bowel disease accounts for significant patient morbidity in the Western world. Several immunosuppressive therapies are available but are associated with potential significant adverse effects. In addition, there remains a cohort of patients with refractory or relapsing disease. Therefore...
Na minha lista:
| Publicado no: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667487/ https://ncbi.nlm.nih.gov/pubmed/24356385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.MIB.0000437616.37000.41 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|